Old Web
English
Sign In
Acemap
>
authorDetail
>
Hong-jiu Dai
Hong-jiu Dai
Chimeric antigen receptor
NKG2D
Medicine
Cancer research
Pathology
6
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (6)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Eradication of medulloblastoma by NKG2D-specific CAR T-cells.
2020
Journal of Clinical Oncology
Hong-jiu Dai
Bin Sun
Dong Yang
Hui Xu
Jingjing Zhu
Jia Wei
Xudong Zhao
Show All
Source
Cite
Save
Citations (1)
Clinical anti-lymphoma effect of T cells expressing an anti-CD19 chimeric antigen receptor in synthetic biology optimizing system.
2020
Journal of Clinical Oncology
Hong-jiu Dai
Yanyun Li
Lan Shi
Hui Dai
Yan Li
Hui Xu
Jingjing Zhu
Pei-xian Zhang
Show All
Source
Cite
Save
Citations (0)
Eradication of hepatocellular carcinoma by NKG2D-specific CAR T-cells
2019
Cancer immunology research
Bin Sun
Dong Yang
Hong-jiu Dai
Xiuyun Liu
Ru Jia
Xiaoyue Cui
Wenxuan Li
Changchun Cai
Jianming Xu
Xudong Zhao
Show All
Source
Cite
Save
Citations (25)
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
2019
Journal for ImmunoTherapy of Cancer
Dong Yang
Bin Sun
Hong-jiu Dai
Wenxuan Li
Lan Shi
Pei-xian Zhang
Shirong Li
Xudong Zhao
Show All
Source
Cite
Save
Citations (21)
Development of NKG2D chimeric antigen receptor-T cells as targeted therapy of liver cancer.
2018
Journal of Clinical Oncology
Hong-jiu Dai
Dong Yang
Bin Sun
Yu-Bo Jiang
Ru Jia
Jianming Xu
Xudong Zhao
Show All
Source
Cite
Save
Citations (1)
NKG2D chimeric antigen receptor-T cells to target GBM.
2018
Journal of Clinical Oncology
Hong-jiu Dai
Dong Yang
Bin Sun
Lan Shi
Pei-xian Zhang
Xudong Zhao
Show All
Source
Cite
Save
Citations (0)
1